Donga CHAMMED Participates in 'LMCE 2025'... Showcases Blood Collection Automation and IBD Diagnostic Solutions

Donga CHAMMED, a subsidiary of Dong-A ST, announced on the 4th that it participated in the '2025 Korean Society for Laboratory Medicine International Conference (LMCE 2025)' held at the Inspire Convention Center in Incheon from October 29 to 31.

LMCE 2025 is a leading academic conference in the field of laboratory medicine in Korea, organized annually by the Korean Society for Laboratory Medicine. It has established itself as an international academic event where experts from around the world gather for scholarly exchange.

At this exhibition, Donga CHAMMED showcased equipment that improves the efficiency of the blood collection process, such as 'HENe', 'FLEXTRAC', and the IBD test reagent 'LIAISON Calprotectin', which can be used on the automated immunoassay analyzer LIAISON XL.

'HENe' is a device that automatically prints patient information on labels and attaches them to tubes by interfacing with hospital EMR (Electronic Medical Record) systems. It supports the use of various types of tubes and enables high-volume sample loading and rapid tube discharge, reducing waiting times. Its user-friendly interface enhances convenience throughout the entire blood collection process, including patient calling, verification, sample information confirmation, and statistical analysis.

'FLEXTRAC' is a device that quickly and conveniently transports collected samples to the desired location via a tube conveyor system. It allows for the simultaneous loading of both small and large quantities of tubes and can be flexibly installed in various layouts to suit hospital environments, enabling efficient workflow design.

'LIAISON Calprotectin' is an in vitro diagnostic reagent used with the automated immunoassay analyzer LIAISON XL. It measures calprotectin levels in stool samples to differentiate between irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), as well as to monitor disease activity and assess the risk of recurrence. LIAISON Calprotectin offers high sensitivity and accuracy.

A representative from Donga CHAMMED stated, "We are striving to improve clinical efficiency for healthcare professionals and create a patient-centered diagnostic environment through blood collection automation solutions and IBD diagnostic solutions. We will continue to develop innovative diagnostic solutions to further strengthen our competitiveness in both domestic and global diagnostic markets."

Meanwhile, Donga CHAMMED, a subsidiary of Dong-A ST, is a total medical healthcare company encompassing: ▲ a medical device division that manufactures, sells, and exports ENT diagnostic equipment and medical imaging devices; ▲ an in vitro diagnostics division that supplies blood collection consumables and in vitro diagnostic medical devices; and ▲ an infection control division that provides space disinfection systems, endoscope disinfectors, dedicated disinfectants, and disinfectant wipes.

This content was produced with the assistance of AI translation services.